MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease

RW. Ou, QQ. Wei, YB. Hou, XQ. Yuan, HF. Shang (Chengdu, China)

Meeting: 2019 International Congress

Abstract Number: 1010

Keywords: Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: The objective of this study was to examine the predictors of body weight loss in PD patients over years.

Background: Early body weight loss in parkinsonism has prognostic significance, and targeted interventions to prevent it may improve long-term outcomes. However, the evolution and determinants of body weight loss in Parkinson’s disease (PD) are not well established.

Method: We examined the percentage of body weight change over years among 152 newly diagnosed PD patients at baseline. Body weight were recorded both at baseline and follow-up visit. The Hoehn and Yahr (H&Y) stage and Unified PD Rating Scale (UPDRS) part III score were used to evaluate the severity of motor symptoms. The Montreal Cognitive Scale (MoCA), Frontal Assessment Battery (FAB), Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating Scale (HARS) were used to assess the severity of non-motor symptoms. The change of body weight > 5% were considered as body weight loss.

Results: We included 68 men and 84 women, with a mean age of 57.0 ± 12.4 years and a mean duration of 2.3 ± 3.3 years. We collected data again 2.4 ± 1.0 years (range from 0.8 to 6.1 years) after the first visit. Thirty-four PD (22.4%) patients with body weight loss over the entire follow-up visit. Patients with body weight loss exhibited higher UPDRS part III score, higher H&Y score and lower MoCA score at baseline compared with those without body weigh loss (P<0.05). The body weights of PD patients at baseline were 59.3 ± 9.6 kg, while those at follow-up visit were 59.0 ± 9.8 kg. Univariate cox regression analysis indicated that age, disease duration, PD family history, freezing of gait and MoCA score were associated with the body weight loss in PD (P<0.05). In the multivariable analysis of COX model, disease duration (HR=0.316, 95%CI=0.207-0.515, P<0.001) and MoCA score (HR=0.921, 95%CI=0.873-0.973, P=0.003) were the independent prognostic risk factors for body weight loss in PD.

Conclusion: Our study indicates that cognitive dysfunction can predict the body weight loss in patients with PD.

To cite this abstract in AMA style:

RW. Ou, QQ. Wei, YB. Hou, XQ. Yuan, HF. Shang. Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-dysfunction-can-predict-the-body-weight-loss-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-dysfunction-can-predict-the-body-weight-loss-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley